DGAP-CMS: Fresenius Medical Care AG & Co. KGaA: Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act]
Fresenius Medical Care AG & Co. KGaA: Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

22.02.2022 / 20:36
Dissemination of a Post-admission Duties announcement according to Article 50 Para. 1, No. 2 WpHG transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Fresenius Medical Care AG & Co. KGaA has filed its report on Form 20-F for the full year 2021 with the U.S. Securities and Exchange Commission(SEC). The report is available on the website
https://www.freseniusmedicalcare.com/en/investors/publications.

22.02.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de